Skip to content

Clinical trials

Observational Scleroderma, Systemic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Observational Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20135
20141
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed2
Recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion2
Royal Brompton & Harefield NHS Foundation Trust2
Gabriela Riemekasten1
Gabriele Valentini1
Prof. Laszlo Czirjak1
Relation Therapeutics1
University of Manchester1
University of Paris 5 - Rene Descartes1
University of the West of England1
marco matucci cerinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic12
Hypertension, Pulmonary2
Lung Diseases, Interstitial2
Scleroderma, Diffuse2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Arrhythmias, Cardiac1
Arthritis1
Gastroesophageal Reflux1
Heart Block1
Heart Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.